Department of Molecular Medicine, Faculty of Medicine, Laval University, Quebec, QC G1V 0A6, Canada.
Functional Genomics Laboratory, Endocrinology and Nephrology Axis, CHU de Québec-Université Laval Research Center, Quebec, QC G1V 4G2, Canada.
Genes (Basel). 2022 Jun 4;13(6):1014. doi: 10.3390/genes13061014.
Long periods of immobilization, among other etiologies, would result is muscle atrophy. Exercise is the best approach to reverse this atrophy. However, the limited or the non-ability to perform the required physical activity for such patients and the limited pharmacological options make developing novel therapeutic approaches a necessity. Within this context, secreted protein acidic and rich in cysteine () has been characterized as an exercise-induced gene. Whereas the knock-out of this gene leads to a phenotype that mimics number of the ageing-induced and sarcopenia-related changes including muscle atrophy, overexpressing SPARC in mice or adding it to muscular cell culture produces similar effects as exercise including enhanced muscle mass, strength and metabolism. Therefore, this piece of writing aims to provide evidence supporting the potential use of /SPARC as a molecular therapy for muscle atrophy in the context of immobilization especially for elderly patients.
长时间的固定不动等病因会导致肌肉萎缩。锻炼是逆转这种萎缩的最佳方法。然而,对于这些患者来说,进行所需的体育活动的能力有限或无法进行,并且药理学选择有限,这使得开发新的治疗方法成为必要。在这种情况下,富含半胱氨酸的酸性分泌蛋白()已被确定为一种运动诱导基因。而敲除该基因会导致表型类似于许多与衰老和肌肉减少症相关的变化,包括肌肉萎缩,在小鼠中过表达 SPARC 或在肌肉细胞培养物中添加 SPARC 会产生类似于运动的类似效果,包括增加肌肉质量、力量和代谢。因此,本文旨在提供支持将 /SPARC 用作固定特别是老年患者肌肉萎缩的分子治疗的证据。